articles and announcements

Latest News

August 28, 2013

Research on Topoisomerase Inhibitors

University of North Carolina-Chapel Hill Research Overview and Frequently Asked Questions The Angelman Syndrome Foundation previously supported breakthrough research showing that topoisomerase inhibitors—specifically, topotecan, an FDA-approved drug used in cancer treatments—activates the paternal allele of Ube3a, identifying a possible treatment […]

Read more
June 18, 2013

ASF Invests $1.25 Million in Research

Angelman Syndrome Foundation Invests $1.25 Million in Research The Angelman Syndrome Foundation (ASF) announced today that because of the generosity of its supporters the organization has awarded $1.25 million to six research grants focused on finding treatments and defining the […]

Read more
February 4, 2013

International Angelman Day – 15 Ways to Celebrate

International Angelman Day – 15 Ways to Celebrate on February 15th The Angelman Syndrome Foundation is excited to celebrate the first ever – International Angelman Day on February 15th. To help raise awareness for Angelman syndrome across the world and […]

Read more
Angelman Syndrome Clinic Network
October 22, 2012

Angelman Syndrome Clinic Opens at Massachusetts General Hospital

Second Angelman Syndrome Clinic Opens at Massachusetts General Hospital Comprehensive Support for Individuals with Angelman syndrome from Infancy through Adulthood BOSTON, October 23, 2012 – Massachusetts General Hospital (MGH), MassGeneral Hospital for Children and the Angelman Syndrome Foundation (ASF) announced […]

Read more
May 21, 2012

Possible Cause of Seizures in Angelman Syndrome

Research Reveals Possible Root Cause of Seizures in Autism-related Angelman Syndrome Research published on June 6th in the scientific peer-reviewed journal Neuron has discovered the possible underlying cause of seizures in individuals with Angelman syndrome, a neuro-genetic disorder similar to autism that […]

Read more